Redston, Mark
Harvard Medical School,
United States
2024 Rank: 100157
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Pathology
Rank in SubField 1: 3902 out of 334837 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 100157 | 110764 |
| Total Cites | 15423 | 16943 |
| H-index | 59 | 60 |
| Hm-index | 14 | 14 |
| Number of Single Authored Papers | 4 | 4 |
| Total Cites to Single Authored Papers | 61 | 64 |
| Number of Single+First Authored Papers | 12 | 12 |
| Total Cites to Single+First Authored Papers | 711 | 790 |
| Number of Single+First+Last Authored Papers | 26 | 26 |
| Total Cites to Single+First+Last Authored Papers | 2190 | 2374 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 12630 | 13485 |
| Ratio of Total Citations to Distinct Citing Papers | 1.22 | 1.26 |
| Self-Citation Percentage |
8.97%
|
|
Redston, Mark
Brigham and Women's Hospital,
2022 Rank: 81975
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Pathology
Rank in SubField 1: 3327 out of 293195 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 81975 | 91494 |
| Total Cites | 14510 | 15975 |
| H-index | 56 | 58 |
| Hm-index | 14 | 14 |
| Number of Single Authored Papers | 3 | 3 |
| Total Cites to Single Authored Papers | 60 | 62 |
| Number of Single+First Authored Papers | 11 | 11 |
| Total Cites to Single+First Authored Papers | 783 | 859 |
| Number of Single+First+Last Authored Papers | 23 | 23 |
| Total Cites to Single+First+Last Authored Papers | 2165 | 2343 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 11816 | 12638 |
| Ratio of Total Citations to Distinct Citing Papers | 1.23 | 1.26 |
| Self-Citation Percentage |
9.17%
|
|
Redston, Mark
Harvard Medical School,
United States
2021 Rank: 79949
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Pathology
Rank in SubField 1: 3262 out of 271773 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 79949 | 89369 |
| Total Cites | 14129 | 15534 |
| H-index | 56 | 58 |
| Hm-index | 14 | 14 |
| Number of Single Authored Papers | 3 | 3 |
| Total Cites to Single Authored Papers | 55 | 57 |
| Number of Single+First Authored Papers | 11 | 11 |
| Total Cites to Single+First Authored Papers | 751 | 820 |
| Number of Single+First+Last Authored Papers | 23 | 23 |
| Total Cites to Single+First+Last Authored Papers | 2097 | 2267 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 11502 | 12297 |
| Ratio of Total Citations to Distinct Citing Papers | 1.23 | 1.26 |
| Self-Citation Percentage |
9.04%
|
|
Redston, Mark
Inform Diagnostics Research Institute,
United States
2020 Rank: 73643
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Pathology
Rank in SubField 1: 3181 out of 230678 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 73643 | 82127 |
| Total Cites | 13424 | 14816 |
| H-index | 55 | 57 |
| Hm-index | 14 | 14 |
| Number of Single Authored Papers | 3 | 3 |
| Total Cites to Single Authored Papers | 52 | 54 |
| Number of Single+First Authored Papers | 11 | 11 |
| Total Cites to Single+First Authored Papers | 727 | 796 |
| Number of Single+First+Last Authored Papers | 23 | 23 |
| Total Cites to Single+First+Last Authored Papers | 2027 | 2197 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 10896 | 11678 |
| Ratio of Total Citations to Distinct Citing Papers | 1.23 | 1.27 |
| Self-Citation Percentage |
9.40%
|
|